Speaker Name: 
GU Oncology Debates 1) Docetaxel vs. Abiraterone in Metastatic Hormone Sensitive Prostate Cancer; 2) 1st Line Treatment in Good Risk Metastatic Renal Cell Carcinoma Daniel J. George, MD Professor Division of Medical Oncology Director, GU Oncology Du
Location: 
143 Jones Bldg
Durham, NC 27701
United States
Session date: 
Wednesday, May 30, 2018 - 7:30am to 9:00am
Credit:
  • 1.50 AMA PRA Category 1 Credit(s)
  • 1.50 Attendance

Please login or register to take this course.